Addressing Patient Inquiries about Specific Medications Advertised Directly to Consumers
Does your stomach sink and your pulse increase when patients ask you about a medicine they’ve seen on TV? Have you ever "just prescribed it", but wondered if you could do something differently without adding 10 minutes to the office visit? This educational module will provide an overview of patients' and physicians' views on direct to consumer advertising (DTCA), summarize the impact of DTCA on patient/physician relationships, describe the impact of DTCA on physician prescribing, and provide tools for addressing patient inquiries about heavily marketed medications. » Go to this activity

Retroperitoneal Lymph Node Dissection in Testis Cancer
RPLND alone provides up to 90% cure in patients with low-volume, low-risk testis cancer and eliminates the risk of teratoma and viable tumor in the retroperitoneum in those with high-risk disease. The morbidity rate associated with this procedure is low, thanks to the modified-template RPLND and nerve-sparing approaches. » Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.